Literature DB >> 20728072

Quantification of vaginal support: are continuous summary scores better than POPQ stage?

Linda Brubaker1, Matthew D Barber, Ingrid Nygaard, Charlie W Nager, Edward Varner, Joseph Schaffer, Anthony Visco, Susan Meikle, Cathie Spino.   

Abstract

OBJECTIVE: This analysis compared 3 continuous variables as summary support loss (SL) scores with pelvic organ prolapse (POP) quantification (POPQ) ordinal stages. STUDY
DESIGN: We used pooled baseline data from 1141 subjects in 3 randomized trials (CARE, n = 322; OPUS, n = 380; ATLAS, n = 439) to test 3 SL measures. The relative responsiveness was assessed using the standardized response mean of 2-year outcome data from the CARE trial.
RESULTS: Each SL measure was strongly correlated with POPQ ordinal staging; the single most distal POPQ point had the strongest correlation. Improvements in anatomic support were weakly correlated with improvements in POP Distress Inventory (r = 0.17-0.24; P < .01 for each) but not with changes in POP Impact Questionnaire for all measures of SL or POPQ stage.
CONCLUSION: While continuous, single number summary measures compared favorably to ordinal POPQ staging system, the single most distal POPQ point may be preferable to POPQ ordinal stages to summarize or compare group data.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728072      PMCID: PMC2975822          DOI: 10.1016/j.ajog.2010.06.071

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

1.  Defining clinically meaningful change in health-related quality of life.

Authors:  Ross D Crosby; Ronette L Kolotkin; G Rhys Williams
Journal:  J Clin Epidemiol       Date:  2003-05       Impact factor: 6.437

2.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  Correlation of symptoms with location and severity of pelvic organ prolapse.

Authors:  R M Ellerkmann; G W Cundiff; C F Melick; M A Nihira; K Leffler; A E Bent
Journal:  Am J Obstet Gynecol       Date:  2001-12       Impact factor: 8.661

4.  Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders.

Authors:  M D Barber; M N Kuchibhatla; C F Pieper; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2001-12       Impact factor: 8.661

5.  The standardization of terminology for researchers in female pelvic floor disorders.

Authors:  A M Weber; P Abrams; L Brubaker; G Cundiff; G Davis; R R Dmochowski; J Fischer; T Hull; I Nygaard; A C Weidner
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

6.  Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050.

Authors:  Jennifer M Wu; Andrew F Hundley; Rebekah G Fulton; Evan R Myers
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

7.  Prevalence of symptomatic pelvic floor disorders in US women.

Authors:  Ingrid Nygaard; Matthew D Barber; Kathryn L Burgio; Kimberly Kenton; Susan Meikle; Joseph Schaffer; Cathie Spino; William E Whitehead; Jennifer Wu; Debra J Brody
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

8.  Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence.

Authors:  Linda Brubaker; Ingrid Nygaard; Holly E Richter; Anthony Visco; Anne M Weber; Geoffrey W Cundiff; Paul Fine; Chiara Ghetti; Morton B Brown
Journal:  Obstet Gynecol       Date:  2008-07       Impact factor: 7.661

9.  Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods.

Authors:  John Wei; Ingrid Nygaard; Holly Richter; Morton Brown; Matthew Barber; Kimberly Kenton; Charles Nager; Joseph Schaffer; Anthony Visco; Anne Weber
Journal:  Clin Trials       Date:  2009-04       Impact factor: 2.486

10.  Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse?

Authors:  Steven E Swift; Susan B Tate; Joyce Nicholas
Journal:  Am J Obstet Gynecol       Date:  2003-08       Impact factor: 8.661

View more
  7 in total

1.  The Design of a Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension Versus Mesh Hysteropexy Suspension (The Study of Uterine Prolapse Procedures Randomized Trial).

Authors:  Charles W Nager; Halina Zyczynski; Rebecca G Rogers; Matthew D Barber; Holly E Richter; Anthony G Visco; Charles R Rardin; Heidi Harvie; Dennis Wallace; Susan F Meikle
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 2.091

Review 2.  Measuring outcomes in urogynecological surgery: "perspective is everything".

Authors:  Candace Y Parker-Autry; Matthew D Barber; Kimberly Kenton; Holly E Richter
Journal:  Int Urogynecol J       Date:  2012-08-29       Impact factor: 2.894

3.  POP-Q 2.0: its time has come!

Authors:  Oz Harmanli
Journal:  Int Urogynecol J       Date:  2014-02-07       Impact factor: 2.894

4.  The POP-Q system: two decades of progress and debate.

Authors:  Richard C Bump
Journal:  Int Urogynecol J       Date:  2014-02-07       Impact factor: 2.894

Review 5.  Open retropubic colposuspension for urinary incontinence in women.

Authors:  Marie Carmela M Lapitan; June D Cody; Atefeh Mashayekhi
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

6.  Comparison of complications and prolapse recurrence between laparoscopic and vaginal uterosacral ligament suspension for the treatment of vaginal prolapse.

Authors:  Lindsay C Turner; Erin S Lavelle; Jonathan P Shepherd
Journal:  Int Urogynecol J       Date:  2015-12-12       Impact factor: 2.894

7.  Transischioanal trans-sacrospinous ligament rectocele repair with polypropylene mesh: a prospective study with assessment of rectoanal function.

Authors:  Pascal Mourtialon; Vincent Letouzey; Georges Eglin; Renaud de Tayrac
Journal:  Int Urogynecol J       Date:  2012-05-16       Impact factor: 2.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.